Evidence map›Paper›PMID 41438705›Full record

ArticleMaterials today. Bio2025

Tumor microenvironment-responsive cerium oxide nanozyme coated ZIF-8 nanoplatform with ICG encapsulation for precise breast cancer surgery and efficacious synergistic suppression.

Tingting Li, Lin Lin, Xiaofen Li, Xin Wang, Jiao Zhang, Lidan Hu, Jianqing Lin, Yuhang Li, Kaiyan Huang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tingting LiThe Second Clinical Medical College of Fujian Medical University, Quanzhou, 362000, Fujian Province, PR China.
Lin LinThe Second Clinical Medical College of Fujian Medical University, Quanzhou, 362000, Fujian Province, PR China.
Xiaofen LiDepartment of Breast Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fuzhou, 350000, Fujian Province, PR China.
Xin WangThe Second Clinical Medical College of Fujian Medical University, Quanzhou, 362000, Fujian Province, PR China.
Jiao ZhangFujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, 350002, Fujian Province, PR China.
Lidan HuDepartment of Biochemistry and Molecular Biology, School of Basic Medicine, University of South China, Hengyang, 421001, Hunan Province, PR China.
Jianqing LinThe Second Clinical Medical College of Fujian Medical University, Quanzhou, 362000, Fujian Province, PR China.
Yuhang LiFujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, 350002, Fujian Province, PR China.
Kaiyan HuangThe Second Clinical Medical College of Fujian Medical University, Quanzhou, 362000, Fujian Province, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Strategically designing and utilizing nanomaterials with enhanced therapeutic capabilities offers a solution to mitigate the financial burden of treatment and address the subpar efficacy of existing breast cancer treatments. In this study, we introduce a one-step synthesis of zeolitic imidazolate framework-8 (ZIF-8) nanoparticles, where indocyanine green (ICG) is encapsulated and CeO

Indexed as

Complete tumor resectionPhotothermal therapyROS stormSynergistic therapyZIF

Identifiers

PMID41438705
PMCPMC12719786

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.